COAPROVEL TABS

Coaprovel Tabs Adverse Events Reported to the FDA Over Time

How are Coaprovel Tabs adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Coaprovel Tabs, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Coaprovel Tabs is flagged as the suspect drug causing the adverse event.

Most Common Coaprovel Tabs Adverse Events Reported to the FDA

What are the most common Coaprovel Tabs adverse events reported to the FDA?

Renal Failure Acute	29 (4.14%)
Hyponatraemia	27 (3.86%)
Hyperkalaemia	16 (2.29%)
Fall	15 (2.14%)
Hypotension	14 (2%)
Malaise	14 (2%)
Vomiting	14 (2%)
Asthenia	13 (1.86%)
Confusional State	13 (1.86%)
Drug Interaction	12 (1.71%)
Hypokalaemia	11 (1.57%)
	Show More
Lactic Acidosis	11 (1.57%)
Dehydration	10 (1.43%)
Dizziness	10 (1.43%)
Bradycardia	9 (1.29%)
Renal Failure	9 (1.29%)
Diarrhoea	8 (1.14%)
Alanine Aminotransferase Increased	7 (1%)
Aspartate Aminotransferase Increase...	7 (1%)
Hepatitis	7 (1%)
Anaemia	6 (.86%)
Bone Marrow Failure	6 (.86%)
Circulatory Collapse	6 (.86%)
Hypertensive Crisis	6 (.86%)
Loss Of Consciousness	6 (.86%)
Pancreatitis Acute	6 (.86%)
Anorexia	5 (.71%)
Gamma-glutamyltransferase Increased	5 (.71%)
Nausea	5 (.71%)
Blood Creatinine Increased	4 (.57%)
Coma	4 (.57%)
Electrocardiogram Qrs Complex Prolo...	4 (.57%)
General Physical Health Deteriorati...	4 (.57%)
Inappropriate Antidiuretic Hormone ...	4 (.57%)
Orthostatic Hypotension	4 (.57%)
Pancytopenia	4 (.57%)
Pregnancy	4 (.57%)
Pyrexia	4 (.57%)
Vertigo	4 (.57%)
Weight Decreased	4 (.57%)
Weight Increased	4 (.57%)
Abdominal Pain Upper	3 (.43%)
Abortion Induced	3 (.43%)
Atrial Fibrillation	3 (.43%)
Atrioventricular Block Complete	3 (.43%)
Bone Sarcoma	3 (.43%)
Colitis	3 (.43%)
Cytolytic Hepatitis	3 (.43%)
Eczema	3 (.43%)
Epistaxis	3 (.43%)
Hypersensitivity	3 (.43%)
Infarction	3 (.43%)
Inflammation	3 (.43%)
Oedema Peripheral	3 (.43%)
Palpitations	3 (.43%)
Somnolence	3 (.43%)
Sudden Death	3 (.43%)
Temperature Intolerance	3 (.43%)
Therapeutic Agent Toxicity	3 (.43%)
Thrombocytopenia	3 (.43%)
Transaminases Increased	3 (.43%)
Urinary Tract Infection	3 (.43%)
Acidosis	2 (.29%)
Acute Generalised Exanthematous Pus...	2 (.29%)
Acute Respiratory Distress Syndrome	2 (.29%)
Agranulocytosis	2 (.29%)
Anxiety	2 (.29%)
Aphthous Stomatitis	2 (.29%)
Atrioventricular Block	2 (.29%)
Benign Prostatic Hyperplasia	2 (.29%)
Bicytopenia	2 (.29%)
Blood Alkaline Phosphatase Increase...	2 (.29%)
Blood Bilirubin Increased	2 (.29%)
Blood Glucose Fluctuation	2 (.29%)
Cholestasis	2 (.29%)
Condition Aggravated	2 (.29%)
Depressed Level Of Consciousness	2 (.29%)
Diabetes Mellitus Inadequate Contro...	2 (.29%)
Dialysis	2 (.29%)
Disorientation	2 (.29%)
Drug Exposure During Pregnancy	2 (.29%)
Dysphagia	2 (.29%)
Electrocardiogram Qt Prolonged	2 (.29%)
Eosinophilia	2 (.29%)
Extrapyramidal Disorder	2 (.29%)
Fatigue	2 (.29%)
Gastroenteritis	2 (.29%)
Hepatic Neoplasm Malignant	2 (.29%)
Hepatomegaly	2 (.29%)
Hyperammonaemia	2 (.29%)
Hypercalcaemia	2 (.29%)
Hyperparathyroidism	2 (.29%)
Hypertension	2 (.29%)
Hypoglycaemia	2 (.29%)
Hypoglycaemic Coma	2 (.29%)
Influenza	2 (.29%)
Interstitial Lung Disease	2 (.29%)
Ketoacidosis	2 (.29%)
Local Swelling	2 (.29%)
Medication Error	2 (.29%)
Metabolic Acidosis	2 (.29%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Coaprovel Tabs, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Coaprovel Tabs is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Coaprovel Tabs

What are the most common Coaprovel Tabs adverse events reported to the FDA?

Electrolyte And Fluid Balance Condi...	64 (9.14%)
Renal Disorders	44 (6.29%)
Neurological	35 (5%)
Gastrointestinal Signs	27 (3.86%)
Decreased And Nonspecific Blood Pre...	26 (3.71%)
Hepatobiliary	24 (3.43%)
Cardiac Arrhythmias	22 (3.14%)
Anemias Nonhemolytic And Marrow Dep...	19 (2.71%)
Hepatic And Hepatobiliary	19 (2.71%)
Injuries	19 (2.71%)
Epidermal And Dermal Conditions	18 (2.57%)
	Show More
Acid-base	17 (2.43%)
Deliria	15 (2.14%)
Therapeutic And Nontherapeutic Effe...	13 (1.86%)
Cardiac And Vascular Investigations	12 (1.71%)
Infections - Pathogen Unspecified	12 (1.71%)
Respiratory	11 (1.57%)
Physical Examination Topics	9 (1.29%)
Gastrointestinal Motility And Defec...	8 (1.14%)
Vascular Hypertensive	8 (1.14%)
Exocrine Pancreas Conditions	7 (1%)
White Blood Cell	7 (1%)
Appetite And General Nutritional	6 (.86%)
Medication Errors	6 (.86%)
Renal And Urinary Tract Investigati...	6 (.86%)
Arteriosclerosis, Stenosis, Vascula...	5 (.71%)
Body Temperature Conditions	5 (.71%)
Chemical Injury And Poisoning	5 (.71%)
Glucose Metabolism Disorders	5 (.71%)
Inner Ear And Viiith Cranial Nerve	5 (.71%)
Lower Respiratory Tract Disorders	5 (.71%)
Muscle	5 (.71%)
Platelet	5 (.71%)
Vascular	5 (.71%)
Allergic Conditions	4 (.57%)
Cardiac Disorder Signs	4 (.57%)
Fatal Outcomes	4 (.57%)
Hypothalamus And Pituitary Gland	4 (.57%)
Pregnancy, Labour, Delivery And Pos...	4 (.57%)
Skeletal Neoplasms Malignant And Un...	4 (.57%)
Anxiety Disorders	3 (.43%)
Bacterial Infectious	3 (.43%)
Gastrointestinal Inflammatory Condi...	3 (.43%)
Headaches	3 (.43%)
Hematology Investigations	3 (.43%)
Hepatobiliary Neoplasms Malignant A...	3 (.43%)
Movement Disorders	3 (.43%)
Musculoskeletal And Connective Tiss...	3 (.43%)
Nephropathies	3 (.43%)
Obstetric And Gynecological Therape...	3 (.43%)
Oral Soft Tissue Conditions	3 (.43%)
Skin And Subcutaneous Tissue	3 (.43%)
Suicidal And Self-injurious Behavio...	3 (.43%)
Upper Respiratory Tract Disorders	3 (.43%)
Urinary Tract Signs	3 (.43%)
Viral Infectious	3 (.43%)
Vision	3 (.43%)
Bladder And Bladder Neck Disorders	2 (.29%)
Bone And Joint Injuries	2 (.29%)
Bone Disorders	2 (.29%)
Bone, Calcium, Magnesium And Phosph...	2 (.29%)
Changes In Physical Activity	2 (.29%)
Coronary Artery	2 (.29%)
Enzyme	2 (.29%)
Gastrointestinal Ulceration And Per...	2 (.29%)
Hematological And Lymphoid Tissue T...	2 (.29%)
Leukemias	2 (.29%)
Metabolic, Nutritional And Blood Ga...	2 (.29%)
Metastases	2 (.29%)
Parathyroid Gland	2 (.29%)
Peripheral Neuropathies	2 (.29%)
Placental, Amniotic And Cavity Diso...	2 (.29%)
Prostatic Disorders	2 (.29%)
Protein And Amino Acid Metabolism	2 (.29%)
Renal And Urinary Tract Disorders C...	2 (.29%)
Respiratory Disorders Congenital	2 (.29%)
Skin Appendage Conditions	2 (.29%)
Tongue Conditions	2 (.29%)
Toxicology And Therapeutic Drug Mon...	2 (.29%)
Vitamin Related	2 (.29%)
Water, Electrolyte And Mineral	2 (.29%)
Abortions And Stillbirth	1 (.14%)
Bone And Joint Therapeutic Procedur...	1 (.14%)
Bronchial Disorders	1 (.14%)
Cardiac Valve	1 (.14%)
Connective Tissue Disorders	1 (.14%)
Family Issues	1 (.14%)
Fungal Infectious	1 (.14%)
Gastrointestinal Hemorrhages	1 (.14%)
Gastrointestinal Neoplasms Malignan...	1 (.14%)
Gastrointestinal Therapeutic Proced...	1 (.14%)
Glaucoma And Ocular Hypertension	1 (.14%)
Joint	1 (.14%)
Lifestyle Issues	1 (.14%)
Lipid Metabolism	1 (.14%)
Mental Impairment	1 (.14%)
Myocardial	1 (.14%)
Neurological Disorders Of The Eye	1 (.14%)
Neuromuscular	1 (.14%)
Ocular Hemorrhages And Vascular	1 (.14%)
Pleural	1 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Coaprovel Tabs, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Coaprovel Tabs is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.